GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Equity-to-Asset

Hisamitsu Pharmaceutical Co (TSE:4530) Equity-to-Asset : 0.80 (As of Nov. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Hisamitsu Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Nov. 2023 was 円269,082 Mil. Hisamitsu Pharmaceutical Co's Total Assets for the quarter that ended in Nov. 2023 was 円334,909 Mil. Therefore, Hisamitsu Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Nov. 2023 was 0.80.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's Equity-to-Asset or its related term are showing as below:

TSE:4530' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.77   Med: 0.82   Max: 0.84
Current: 0.81

During the past 13 years, the highest Equity to Asset Ratio of Hisamitsu Pharmaceutical Co was 0.84. The lowest was 0.77. And the median was 0.82.

TSE:4530's Equity-to-Asset is ranked better than
82.54% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs TSE:4530: 0.81

Hisamitsu Pharmaceutical Co Equity-to-Asset Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Equity-to-Asset Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 0.84 0.84 0.82 0.81

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.81 0.79 0.80 0.81

Competitive Comparison of Hisamitsu Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Equity-to-Asset falls into.



Hisamitsu Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hisamitsu Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Feb. 2024 is calculated as

Equity to Asset (A: Feb. 2024 )=Total Stockholders Equity/Total Assets
=264871/328779
=0.81

Hisamitsu Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

Equity to Asset (Q: Nov. 2023 )=Total Stockholders Equity/Total Assets
=269082/334909
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (TSE:4530) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Hisamitsu Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines